ResearcherHospital Italiano de Buenos AiresNo recent work listed
Eduardo de Santibáñes
Matched on ORCID iD 0000-0002-5788-9694; OpenAlex author ID A5049177641. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2018: 1 paper · 2019: 2 papers · 2020: none · 2021: 1 paper · 2022: none · 2023: 2 papers
Papers 6
- Prognostic Factors in Resected Pancreatic Ductal Adenocarcinoma: Is Neutrophil-Lymphocyte Ratio a Useful Marker? Co-author DOI 10.1007/s12029-022-00839-7↗
- Technical Implications for Surgical Resection in Locally Advanced Pancreatic Cancer. Co-author DOI 10.3390/cancers15051509↗
- [Long-term survival after pancreatic cancer surgery]. Co-author PMID 34633955↗
- Early pancreatic cancer in IgG4-related pancreatic mass: A case report. Last author DOI 10.4240/wjgs.v11.i12.443↗
- [New progress in the treatment of locally advance pancreatic cancer]. Co-author PMID 31864229↗
- Use of radiotherapy in patients with palliative double bypass for locally advanced pancreatic adenocarcinoma. Co-author DOI 10.3857/roj.2018.00206↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Martín de Santibañes · 6 shared papers, 2018–2023 · strength 0.87
- Paper Technical Implications for Surgical Resection in Locally Advanced Pancreatic Cancer. DOI 10.3390/cancers15051509↗
- Paper Prognostic Factors in Resected Pancreatic Ductal Adenocarcinoma: Is Neutrophil-Lymphocyte Ratio a Useful Marker? DOI 10.1007/s12029-022-00839-7↗
- Paper [Long-term survival after pancreatic cancer surgery]. PMID 34633955↗
- Oscar Mazza · 5 shared papers, 2018–2023 · strength 0.78
- Paper Technical Implications for Surgical Resection in Locally Advanced Pancreatic Cancer. DOI 10.3390/cancers15051509↗
- Paper Prognostic Factors in Resected Pancreatic Ductal Adenocarcinoma: Is Neutrophil-Lymphocyte Ratio a Useful Marker? DOI 10.1007/s12029-022-00839-7↗
- Paper [Long-term survival after pancreatic cancer surgery]. PMID 34633955↗
- Ignacio Guillermo Merlo · 2 shared papers, 2021–2023 · strength 0.33
- Juan Glinka · 2 shared papers, 2018–2019 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.